Genenta Science S.p.A. GNTA
Set alert
0.62 USD 0.00 -0.27%
At close · Oct 30
0.60 -0.02 -2.98%
After hours · Oct 30, 4:00 PM ET
0.60 Day range 0.6365
0.58 52-week range 2.87
- YTD
- -58.50%
- 1 year
- -78.46%
- Open
- 0.62
- Prev close
- 0.62
- Mkt cap
- 29.81M
- Vol
- 67.20K
- Avg vol
- 52.62K
- EPS
- -0.37
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.60
- High
- 0.6365
- Forward P/E
- -7.53
- Beta
- 0.74
- Short ratio
- 0.19
- Inst. own
- 7.78%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 5.18
- 200-d avg
- 4.10
- 1y target
- 21.65
2Y chart
Signals (74)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Sep 28, 2026 | 1 month ago |
| RSI: Oversold | Sep 9, 2026 | 1 month ago |
| RSI: Oversold | Sep 3, 2026 | 1 month ago |
| SMA: Bullish | Jul 30, 2026 | 3 months ago |
| SMA: Bearish | Jul 29, 2026 | 3 months ago |
| SMA: Bearish | Jul 29, 2026 | 3 months ago |
| SMA: Bullish | Jul 17, 2026 | 3 months ago |
| SMA: Bullish | Jul 15, 2026 | 3 months ago |
| SMA: Bearish | Jul 14, 2026 | 3 months ago |
| SMA: Bearish | Jul 10, 2026 | 3 months ago |
| SMA: Bullish | Jul 9, 2026 | 3 months ago |
| SMA: Bearish | Jul 8, 2026 | 3 months ago |
| MACD: Sell Signal | Jun 18, 2026 | 4 months ago |
| SMA: Bullish | Jun 11, 2026 | 4 months ago |
| SMA: Bearish | Jun 9, 2026 | 4 months ago |
| SMA: Bullish | Jun 2, 2026 | 5 months ago |
| RSI: Overbought | May 28, 2026 | 5 months ago |
| SMA: Bullish | May 27, 2026 | 5 months ago |
| MACD: Buy Signal | May 27, 2026 | 5 months ago |
| MACD: Sell Signal | May 7, 2026 | 5 months ago |
| MACD: Buy Signal | Mar 26, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 18, 2026 | 7 months ago |
| RSI: Oversold | Mar 18, 2026 | 7 months ago |
| MACD: Buy Signal | Feb 17, 2026 | 8 months ago |
| RSI: Oversold | Feb 3, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 30, 2026 | 9 months ago |
| MACD: Buy Signal | Dec 19, 2025 | 10 months ago |
| RSI: Oversold | Dec 16, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 15, 2025 | 10 months ago |
| MACD: Buy Signal | Nov 26, 2025 | 11 months ago |
| MACD: Sell Signal | Oct 29, 2025 | 1 year ago |
| SMA: Bearish | Oct 27, 2025 | 1 year ago |
| SMA: Bearish | Oct 27, 2025 | 1 year ago |
| SMA: Bullish | Oct 24, 2025 | 1 year ago |
| SMA: Bullish | Oct 24, 2025 | 1 year ago |
| RSI: Overbought | Oct 24, 2025 | 1 year ago |
| SMA: Bearish | Oct 14, 2025 | 1 year ago |
| SMA: Bullish | Oct 13, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 25, 2025 | 1 year ago |
| RSI: Oversold | Sep 11, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 8, 2025 | 1 year ago |
| SMA: Bearish | Sep 2, 2025 | 1 year ago |
| SMA: Bullish | Aug 27, 2025 | 1 year ago |
| SMA: Bearish | Aug 22, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 22, 2025 | 1 year ago |
| SMA: Bullish | Aug 21, 2025 | 1 year ago |
| SMA: Bearish | Aug 8, 2025 | 1 year ago |
| SMA: Bullish | Aug 6, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 4, 2025 | 1 year ago |
| SMA: Bullish | Jul 30, 2025 | 1 year ago |
| SMA: Bearish | Jul 14, 2025 | 1 year ago |
| SMA: Bullish | Jul 11, 2025 | 1 year ago |
| SMA: Bearish | Jul 10, 2025 | 1 year ago |
| SMA: Bullish | Jul 9, 2025 | 1 year ago |
| SMA: Bearish | Jul 8, 2025 | 1 year ago |
| SMA: Bullish | Jul 7, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 1, 2025 | 1 year ago |
| RSI: Oversold | Jun 17, 2025 | 1 year ago |
| SMA: Bearish | Jun 6, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 3, 2025 | 1 year ago |
| MACD: Buy Signal | May 29, 2025 | 1 year ago |
| MACD: Sell Signal | May 23, 2025 | 1 year ago |
| SMA: Bullish | Apr 24, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 16, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 3, 2025 | 1 year ago |
| SMA: Bullish | Mar 26, 2025 | 1 year ago |
| SMA: Bearish | Mar 25, 2025 | 1 year ago |
| SMA: Bullish | Mar 21, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 5, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 31, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 30, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 13, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 10, 2025 | 1 year ago |
| MACD: Sell Signal | Dec 20, 2024 | 1 year ago |
Key statistics
- Market cap
- 89.57M
- Enterprise value
- 74.75M
- Trailing P/E
- 0.00
- Forward P/E
- -7.53
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 5.33
- EPS (TTM)
- -0.51
- Beta
- 0.74
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- -4.45M
- Total cash
- 16.91M
- Total debt
- 21.00K
- Return on equity
- -42.89%
- Shares outstanding
- 18.29M
- Short % of float
- 0.01%
- 50-day average
- 5.18
- 200-day average
- 4.10
Analyst view
Consensus: none
Price target (mean) 21.65 +3402.1% upside
Now 0.6183
- Target (low)
- 19.80
- Target (mean)
- 21.65
- Target (high)
- 23.51
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy2
- Buy0
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
GNTA Revenue — annual 0
GNTA Net income — annual -6.53M
GNTA EPS — annual -0.33
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 2, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| May 13, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Feb 8, 2023 | HC Wainwright & Co. | reit | — | Buy |
| Jan 5, 2023 | EF Hutton | init | — | Buy |
| Jul 25, 2022 | HC Wainwright & Co. | init | — | Buy |
| Jan 13, 2022 | Maxim Group | init | — | Buy |
About Genenta Science S.p.A.
Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. Its lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter. The company is developing Temferon for use in the treatment of other solid tumor indications, locally advanced hepatocellular carcinoma, and intra-hepatic cholangiocarcinoma. In addition, it develops biologic platform to deliver immunomodulatory molecules directly to the tumor by infiltrating monocytes/macrophages. Genenta Science S.p.A. was incorporated in 2014 and is headquartered in Milan, Italy.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- Italy
- Website
- genenta.com
News
- Genenta Science Receives Nasdaq Noncompliance Notice, Gets Time Through April 14, 2027 To Regain Compliance
- Genenta Science Announces Receipt of Nasdaq Minimum Bid Price Deficiency Notification
- 12 Health Care Stocks Moving In Wednesday's After-Market Session
- Sòphia High Tech Flight Hardware on Board VEGA-C VV30 as the European Launcher Carries Sentinel-3C and FLEX into Orbit
- Genenta-backed Sòphia High Tech Brings Aerospace Precision Inside a Nuclear Fusion Reactor with ROMAN, a Robotic Arm
- Genenta-Backed Sòphia High Tech Reports Fiscal Year 2025 Results
- 12 Health Care Stocks Moving In Monday's Pre-Market Session
- 12 Health Care Stocks Moving In Friday's Pre-Market Session
- 12 Health Care Stocks Moving In Thursday's Pre-Market Session
- 12 Health Care Stocks Moving In Tuesday's After-Market Session
Your note
Sign in to keep a note on GNTA — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Alti Global, Inc. | 1.10% | 200,288 | 980.83K | Sep 29, 2024 |
| Algebris (UK) LTD | 0.25% | 45,000 | 220.37K | Sep 29, 2024 |
| UBS Group AG | 0.01% | 1,862 | 9.12K | Sep 29, 2024 |
| Morgan Stanley | 0.00% | 500 | 2.45K | Sep 29, 2024 |